Work

Abstract 572: Development of a targeted copper theranostic to fibroblast activation protein (FAP) which shows high uptake and long-term retention at the tumor site

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-572

Authors: Jaclyn L. Lange, Lachlan E. Mclnnes, Jessica Van Zuylekom, Benjamin Blyth, Stacey E. Rudd, Paul S. Donnelly, Aidan Ingham, Jason S. Lewis, Matthew Harris

Institutions: Clarity Pharmaceuticals Ltd. (Australia), Peter MacCallum Cancer Centre, The University of Melbourne, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409691519

Cites:

Cited by:

Related to: 10